[1] Community respiratory virus infections in immunocompromised patients with cancer

[2] the p36 isoform of murine cytomegalovirus m152 protein suffices for mediating innate and adaptive immune evasion

[3] Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review

[4] Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy

[5] Is cytomegalovirus infection related to inflammatory bowel disease, especially steroid-resistant inflammatory bowel disease? A meta-analysis

[6] Letermovir and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human cytomegalovirus

[7] Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review

[8] Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review

[9] Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy

[10] A Practical Review of Cytomegalovirus in Gastroenterology and Hepatology

[11] Is cytomegalovirus infection related to inflammatory bowel disease, especially steroid-resistant inflammatory bowel disease? A meta-analysis

[12] Letermovir and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human cytomegalovirus

[13] Clinical significance of post-treatment viral load of cytomegalovirus in patients with hematologic malignancies.

[14] Improvement in detecting cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance using next generation sequencing.

[15] Murine Cytomegalovirus Protein pM91 Interacts with pM79 and Is Critical for Viral Late Gene Expression.

[16] Determination of anti-p52 IgM and anti-gB IgG by ELISA as a novel diagnostic tool for detection of early and late phase of primary human cytomegalovirus infections during pregnancy.

[17] The Role of RhoA, RhoB and RhoC GTPases in Cell Morphology, Proliferation and Migration in Human Cytomegalovirus (HCMV) Infected Glioblastoma Cells

[18] Reference gene selection for quantitative real-time PCR analysis in virus infected cells: SARS corona virus, Yellow fever virus, Human Herpesvirus-6, Camelpox virus and Cytomegalovirus infections

[19] Executive Functions, Pragmatic Skills, and Mental Health in Children With Congenital Cytomegalovirus (CMV) Infection With Cochlear Implants: A Pilot Study.

[20] Blood Viral Load in Symptomatic Congenital Cytomegalovirus Infection.

[21] Reconstitution of cytomegalovirus-specific T-cell immunity following unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with posttransplant cyclophosphamide.

[22] A cross-sectional study exploring disease characteristics and phylogenetic nature of human cytomegalovirus among infected neonates with congenital nephrotic syndrome.

[23] High-resolution profiling of human cytomegalovirus cell-free DNA in human plasma highlights its exceptionally fragmented nature

[24] Glial nodule encephalitis in the guinea pig: serial observations following cytomegalovirus infection

[25] serological screening of immunoglobulin m and immunoglobulin g during pregnancy for predicting congenital cytomegalovirus infection

[26] navigating the host cell response during entry into sites of latent cytomegalovirus infection

[27] effective detection of porcine cytomegalovirus using non-invasively taken samples from piglets

[28] role of human cytomegalovirus tegument proteins in virion assembly

[29] trip to immunity: resistant cytomegalovirus infection in a lung transplant recipient

[30] trends in the treatment of cytomegalovirus infection in oncohematological patients

[31] the salivary gland acts as a sink for tissue-resident memory cd8+ t cells, facilitating protection from local cytomegalovirus infection

[32] severe colitis associated with both epstein-barr virus and cytomegalovirus reactivation in a patient with severe aplastic anemia

[33] hemorrhagic intestinal henoch-schonlein purpura complicated by cytomegalovirus infection

[34] direct and indirect effects of cytomegalovirus-induced gamma-delta t cells after kidney transplantation

[35] donor killer immunoglobulin-like receptor genes and reactivation of cytomegalovirus after hla-matched hematopoietic stem-cell transplantation: hla-c allotype is an essential cofactor

[36] murine cytomegalovirus exploits olfaction to enter new hosts

[37] elusive role of the cd94/nkg2c nk cell receptor in the response to cytomegalovirus: novel experimental observations in a reporter cell system

[38] late development of fcεrγneg adaptive natural killer cells upon human cytomegalovirus reactivation in umbilical cord blood transplantation recipients

[39] interaction between human cytomegalovirus ul136 protein and atp1b1 protein

[40] lymphocyte subpopulations during cytomegalovirus disease in renal transplant recipients

[41] community-acquired pneumonia associated with cytomegalovirus persistence: prevalence and peculiarities of clinical course

[42] human cytomegalovirus infection of tumor cells downregulates ncam (cd56): a novel mechanism for virus-induced tumor invasiveness'

[43] seropositivity of cytomegalovirus in patients with recurrent pregnancy loss

[44] incidence and risk of cytomegalovirus infection during pregnancy in an urban area of northern italy

[45] human cytomegalovirus strategies to maintain and promote mrna translation

[46] streptamer versus tetramer-based selection of functional cytomegalovirus-specific t cells

[47] increased il-15 production and accumulation of highly differentiated cd8+ effector/memory t cells in the bone marrow of persons with cytomegalovirus

[48] engineered rnase p ribozymes effectively inhibit human cytomegalovirus gene expression and replication

[49] human cytomegalovirus delays neutrophil apoptosis and stimulates the release of a prosurvival secretome

[50] identification of mouse cytomegalovirus resistance loci by enu mutagenesis

[51] the effects of age and latent cytomegalovirus infection on nk-cell phenotype and exercise responsiveness in man

[52] the p36 isoform of murine cytomegalovirus m152 protein suffices for mediating innate and adaptive immune evasion

[53] primary cytomegalovirus infection causing guillain-barré syndrome in a living renal allograft recipient

[54] intrinsic contribution of perforin to nk-cell homeostasis during mouse cytomegalovirus infection

[55] Preventing Post-Organ Transplantation Cytomegalovirus Disease with Ganciclovir: A Meta-Analysis Comparing Prophylactic and Preemptive Therapies

[56] Monitoring of cytomegalovirus infections by the CD8+CD38+ T-cell subset in kidney transplant recipients

[57] Preemptive ganciclovir for mechanically ventilated patients with cytomegalovirus reactivation

[58] Assessment of Risk Indicators for Targeted Cytomegalovirus Screening in Neonates